Literature DB >> 18762587

Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate.

L Elliot Hong1, Ann Summerfelt, Braxton D Mitchell, Robert P McMahon, Ikwunga Wonodi, Robert W Buchanan, Gunvant K Thaker.   

Abstract

CONTEXT: The auditory sensory gating deficit has been considered a leading endophenotype in schizophrenia. However, the commonly used index of sensory gating, P50, has low heritability in families of people with schizophrenia, raising questions about its utility in genetic studies. We hypothesized that the sensory gating deficit may occur in a specific neuronal oscillatory frequency that reflects the underlying biological process of sensory gating. Frequency-specific sensory gating may be less complex than the P50 response, and therefore closer to the direct genetic effects, and thus a more valid endophenotype.
OBJECTIVES: To compare the gating of frequency-specific oscillatory responses with the gating of P50 and to compare their heritabilities.
DESIGN: We explored single trial-based oscillatory gating responses in people with schizophrenia, their relatives, and control participants from the community.
SETTING: Outpatient clinics. PARTICIPANTS: Persons with schizophrenia (n = 102), their first-degree relatives (n = 74), and control participants from the community (n = 70). MAIN OUTCOME MEASURES: Gating of frequency-specific oscillatory responses, gating of the P50 wave, and their heritability estimates.
RESULTS: Gating of the theta-alpha-band responses of the control participants were significantly different from those with schizophrenia (P < .001) and their first-degree relatives (P = .04 to .009). The heritability of theta-alpha-band gating was estimated to be between 0.49 and 0.83 and was at least 4-fold higher than the P50 heritability estimate.
CONCLUSIONS: Gating of the theta-alpha-frequency oscillatory signal in the paired-click paradigm is more strongly associated with schizophrenia and has significantly higher heritability compared with the traditional P50 gating. This measure may be better suited for genetic studies of the gating deficit in schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 18762587      PMCID: PMC2774756          DOI: 10.1001/archpsyc.65.9.1008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  51 in total

Review 1.  INPUT DYSFUNCTION IN SCHIZOPHRENIA.

Authors:  P H VENABLES
Journal:  Prog Exp Pers Res       Date:  1964

2.  Disorders of attention and perception in early schizophrenia.

Authors:  A MCGHIE; J CHAPMAN
Journal:  Br J Med Psychol       Date:  1961

3.  The gamma band response may account for poor P50 suppression in schizophrenia.

Authors:  B A Clementz; L D Blumenfeld; S Cobb
Journal:  Neuroreport       Date:  1997-12-22       Impact factor: 1.837

4.  Heritability of inhibitory gating of the P50 auditory-evoked potential in monozygotic and dizygotic twins.

Authors:  D A Young; M Waldo; J H Rutledge; R Freedman
Journal:  Neuropsychobiology       Date:  1996       Impact factor: 2.328

5.  Multipoint quantitative-trait linkage analysis in general pedigrees.

Authors:  L Almasy; J Blangero
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

6.  Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects.

Authors:  B A Clementz; M A Geyer; D L Braff
Journal:  Schizophr Res       Date:  1998-02-27       Impact factor: 4.939

Review 7.  Elementary phenotypes in the neurobiological and genetic study of schizophrenia.

Authors:  L E Adler; R Freedman; R G Ross; A Olincy; M C Waldo
Journal:  Biol Psychiatry       Date:  1999-07-01       Impact factor: 13.382

8.  The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study.

Authors:  T D Cannon; J Kaprio; J Lönnqvist; M Huttunen; M Koskenvuo
Journal:  Arch Gen Psychiatry       Date:  1998-01

9.  Poor P50 suppression among schizophrenia patients and their first-degree biological relatives.

Authors:  B A Clementz; M A Geyer; D L Braff
Journal:  Am J Psychiatry       Date:  1998-12       Impact factor: 18.112

10.  P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia.

Authors:  E M Sánchez-Morla; M A García-Jiménez; A Barabash; V Martínez-Vizcaíno; J Mena; J A Cabranes-Díaz; E Baca-Baldomero; J L Santos
Journal:  Acta Psychiatr Scand       Date:  2008-01-30       Impact factor: 6.392

View more
  57 in total

1.  Distinct neural generators of sensory gating in schizophrenia.

Authors:  Terrance J Williams; Keith H Nuechterlein; Kenneth L Subotnik; Cindy M Yee
Journal:  Psychophysiology       Date:  2010-08-23       Impact factor: 4.016

2.  Epigenetics as a unifying principle in the aetiology of complex traits and diseases.

Authors:  Arturas Petronis
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 3.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

4.  Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.

Authors:  Valerie M Tatard-Leitman; Catherine R Jutzeler; Jimmy Suh; John A Saunders; Eddie N Billingslea; Susumu Morita; Rachel White; Robert E Featherstone; Rabindranath Ray; Pavel I Ortinski; Anamika Banerjee; Michael J Gandal; Robert Lin; Anamaria Alexandrescu; Yuling Liang; Raquel E Gur; Karin E Borgmann-Winter; Gregory C Carlson; Chang-Gyu Hahn; Steven J Siegel
Journal:  Biol Psychiatry       Date:  2014-07-18       Impact factor: 13.382

5.  "Familiality" or heritability.

Authors:  Kenneth S Kendler; Michael C Neale
Journal:  Arch Gen Psychiatry       Date:  2009-04

Review 6.  Radial cytoarchitecture and patterns of cortical connectivity in autism.

Authors:  Manuel Casanova; Juan Trippe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-05-27       Impact factor: 6.237

Review 7.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

Review 8.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

9.  Spectral decomposition of P50 suppression in schizophrenia during concurrent visual processing.

Authors:  Zachary D Moran; Terrance J Williams; Peter Bachman; Keith H Nuechterlein; Kenneth L Subotnik; Cindy M Yee
Journal:  Schizophr Res       Date:  2012-07-25       Impact factor: 4.939

Review 10.  Cellular and circuit models of increased resting-state network gamma activity in schizophrenia.

Authors:  R S White; S J Siegel
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.